Professional Documents
Culture Documents
LPR adalah suatu penyakit yang ditandai dengan adanya inflamasi dan
iritasi laryng sehingga pada pasien akan timbul gejala suara serak,
berkurangnya volume suara, batuk yang kronik, rasa tertekan pada
tenggorok bagian belakang, kesulitan untuk bernafas dan nyeri tenggorok.
OBJECTIV
The aim of this study was to investigate the effectiveness of PPI twice daily vs
placebo in treating
LPR by using a double-blind, placebo-controlled design
Metode
INKLUSI
Patients diagnosed with posterior laryngitis associated with hoarseness, cough,
throat clearing, throat discomfort and globus sensation, and who were found to
have GORD-related laryngeal mucosal changes were invited to participate in this
study.
Eksklusi
Patients were excluded from the study if they were currently on antireflux
treatment, had prior antireflux or other oesophageal or gastric surgery, had
undergone endotracheal intubation within the last 3 months, were diagnosed
with oropharyngeal or laryngeal cancer, were pregnant, or had an allergy to a
PPI. In addition, patients with severe comorbidity (cardiovascular, respiratory,
renal, hepatic, hematologic, neurologic, or psychiatric), diabetes mellitus,
scleroderma, gastroparesis, active peptic ulcer disease, taking prokinetic agents
or narcotics were excluded from the study. Patients who were unable to sign an
informed consent or complete all stages of the study were excluded as well
Hamil
Alergi PPI
Memiliki penyakit yang berhubungan dengan kardiovaskuler , sitem
pernafasan, ginjal, hepar, kelainan darah, syaraf dan gangguan jiwa,
diabetes mellitus, scleroderma, gastroparesis, peptic ulcer
Konsumsi obat prokinetic or narcotics
Pasein yang tidak dapat menandatangani inform consent
Pasein yang gugur pada tahap pemeriksaan.
evaluasi
evaluation of all participants was performed using the GORD Symptom Checklist,
the Short Form 36 (SF-36), the Laryngopharyngeal Reflux Health-Related Quality
of Life Questionnaire (LPR-HRQL), and the Demographics Questionnaire.
Subsequently, patients underwent oesophagogastroduodenoscopy, ambulatory
24-h oesophageal pH monitoring, videostroboscopic recording of the larynx, and
acoustic recordings of voice and speech tasks for analysis and perceptual
ratings.
Pasien yang telah di evaluasi dengan checklist GORD Symptom, the Short
Form 36 (SF-36), the Laryngopharyngeal Reflux Health-Related Quality of
Life Questionnaire (LPR-HRQL), and the Demographics Questionnaire.
Selanjutnya pasien diperiksa dengan oesophagogastroduodenoscopy,
ambulatory 24-h oesophageal pH monitoring, videostroboscopic recording
of the larynx serta pemeriksaan pada suara dan pengucapan untuk
analisis
Patients completed a Daily Voice Use and Quality Diary for 1 week at baseline
and during weeks 4, 8, and 12 of the treatment period. Patients also repeated a
GORD symptom record diary for 7 days during week 12. On the last day of
treatment, the SF-36 and LPR-HRQL were administered, and videostroboscopic
recordings and acoustic recordings of voice and speech tasks were collected as
well.
Demographical Questionnaire
The demographical questionnaire obtained information regarding participants_
age, gender, ethnicity, college education, income and other demographical
parameters.
Upper endoscopy
Upper endoscopy was performed to evaluate the distal oesophagus and to
determine the presence of mucosal injury. The stomach and duodenum were
evaluated for possible mucosal lesions as well.
The SF-36 is a generic HRQL tool that includes eight multi-item scales. The SF-36
evaluates the extent to which an individual_s health limits his or her physical,
emotional or social functioning.